Holen Sie sich die Stockscreener-App
74.26
0.21%
-0.16
Handel nachbörslich:
70.91
-3.35
-4.51%
Schlusskurs vom Vortag:
$74.42
Offen:
$74.79
24-Stunden-Volumen:
1.66M
Relative Volume:
1.20
Marktkapitalisierung:
$12.86B
Einnahmen:
$8.28B
Nettoeinkommen (Verlust:
$1.43B
KGV:
9.0958
EPS:
8.1642
Netto-Cashflow:
$-203.00M
1W Leistung:
+1.20%
1M Leistung:
+7.47%
6M Leistung:
-1.85%
1J Leistung:
+1.81%
1-Tages-Spanne:
$74.03
$75.86
1-Wochen-Bereich:
$72.60
$75.91
52-Wochen-Spanne:
$62.38
$88.20
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
1750 YANKEE DOODLE ROAD, EAGAN
Compare SOLV vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
74.26 | 12.89B | 8.28B | 1.43B | -203.00M | 8.1642 |
ISRG
Intuitive Surgical Inc
|
421.12 | 151.60B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
143.47 | 39.81B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
63.64 | 31.21B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.19 | 32.89B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
201.88 | 29.37B | 5.54B | 1.52B | 1.74B | 10.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-24 | Eingeleitet | Rothschild & Co Redburn | Sell |
| 2026-01-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2026-01-20 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-12-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-09-11 | Eingeleitet | Jefferies | Hold |
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Argus | Hold → Buy |
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Solventum (NYSE: SOLV) CHRO settles RSUs with tax withholding, updates share stake - Stock Titan
Solventum (SOLV) CFO exercises RSUs and uses 4,404 shares for taxes - Stock Titan
Solventum (SOLV) supply chain chief exercises 3,960 RSUs, 1,678 shares withheld for tax - Stock Titan
Solventum (NYSE: SOLV) CAO vests RSUs; 728 shares withheld for taxes - Stock Titan
Solventum (SOLV) legal chief exercises 4,488 RSUs, with 1,952 shares for tax - Stock Titan
Solventum (SOLV) CEO exercises RSUs, uses 13,503 shares for tax withholding - Stock Titan
Solventum (SOLV) CIO exercises 4,422 RSUs, withholds 2,017 shares for taxes - Stock Titan
3M Company stock (US88579Y1010): spin-off of Solventum reshapes the industrial conglomerate - AD HOC NEWS
3M (MMM) Spin-off Solventum Receives Outperform Rating from Wedb - GuruFocus
Solventum Seen Positioned for Meaningful Re-Rating Over Next 12 to 18 Months, Wedbush Says - marketscreener.com
Wedbush Initiates Solventum at Outperform With $94 Price Target - marketscreener.com
Wedbush initiates Solventum stock coverage at Outperform - Investing.com
Solventum’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Solventum Stock Tumbles as Tariff Fears Mount - TipRanks
Solventum Foundation and America's ToothFairy Launch National Effort to Expand Access to Preventive Dental Care - PR Newswire
Solventum gains after activist Trian sends letter urging changes (update) - MSN
Solventum (SOLV) Q4 2025 Earnings Call Transcript - Fortune
Why Solventum’s (NYSE:SOLV) Story Deserves Closer Attention? - Kalkine Media
Solventum's (NYSE:SOLV) Solid Earnings May Rest On Weak Foundations - simplywall.st
Solventum Stock On Fire: Up 13% With 7-Day Winning Streak - Trefis
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
Solventum (SOLV) Recently Broke Out Above the 200-Day Moving Average - Yahoo Finance
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Why Solventum (SOLV) Is Up 8.8% After Beating Adjusted Q1 Estimates And Reaffirming 2026 Outlook - Yahoo Finance
Is It Time To Reassess Solventum (SOLV) After Its Recent Share Price Rebound? - Yahoo Finance
Solventum stock is recovering: What's going on? - MSN
Why Solventum (SOLV) is a top momentum stock for the long term - MSN
Why Solventum (SOLV) Is Up 6.4% After Reaffirming 2026 Outlook Despite Softer Q1 Results – And What's Next - simplywall.st
Solventum forecasts annual profit at higher end on wound care demand - MSN
Solventum Q1 FY26 slides: EPS beats forecast, margins expand to 19.5% - Investing.com India
Solventum Corp. stock rises Friday, outperforms market - MarketWatch
Peltz's Trian urges Solventum to rightsize costs, divest non-core businesses - MSN
Earnings call transcript: Solventum Q1 2026 earnings beat expectations - Investing.com UK
Earnings call transcript: Solventum Q1 2026 earnings beat expectations By Investing.com - Investing.com South Africa
Solventum (SOLV) Q1 2026 Earnings Transcript - AOL.com
Solventum (SOLV) tops Q1 earnings and revenue estimates - MSN
Research Alert: CFRA Maintains Hold On Shares Of Solventum Corporation - Moomoo
Solventum executives take the stage at BofA health conference May 13 - Stock Titan
Solventum to Participate in the 2026 BofA Securities Health Care Conference - marketscreener.com
Why Solventum (SOLV) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Wells Fargo Keeps Their Hold Rating on Solventum Corporation (SOLV) - The Globe and Mail
Solventum Bets On 20 Product Launches To Power Post-3M Growth - Citeline News & Insights
Solventum Beats Consensus Estimates for 1Q26 - Medical Device and Diagnostic industry
Solventum (SOLV) Q1 Earnings Slump As Margin Compression Tests Bullish Narratives - simplywall.st
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
Solventum Stock Down Despite Q1 Earnings & Revenues Beat Estimates - TradingView
UBS Adjusts Price Target on Solventum to $78 From $82, Maintains Neutral Rating - marketscreener.com
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.28%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):